Vascular cognitive change: Perspective from neurology

Alzheimer's and Dementia

Volumn 3, Issue 2 SUPPL., 2007, Pages

  McKhann, Guy M ^a   Selnes, Ola A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; CANDESARTAN; DONEPEZIL; GALANTAMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDAPAMIDE; MEMANTINE; NONSTEROID ANTIINFLAMMATORY AGENT; PERINDOPRIL; PLACEBO;

ALZHEIMER DISEASE; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; DEMENTIA; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LOW DRUG DOSE; MULTIINFARCT DEMENTIA; NEUROLOGY; OFF PUMP CORONARY SURGERY; PRIORITY JOURNAL; RISK ASSESSMENT; SUBCORTICAL SMALL VESSEL ISCHEMIC DISEASE;

EID: 34147165520     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2007.01.012     Document Type: Article

References (27)

1. Selnes O.A., McKhann G.M., Borowicz Jr. L.M., and Grega M.A. Cognitive and neurobehavioral dysfunction after cardiac bypass procedures. Neurol Clin 24 (2006) 133-145
2. Coffey C.E., Massey E.W., Roberts K.B., Curtis S., Jones R.H., and Pryor D.B. Natural history of cerebral complications of coronary artery bypass graft surgery. Neurology 33 (1983) 1416-1421
3. Johns Hopkins University database (2003)
4. McKhann G.M., Grega M.A., Borowicz Jr. L.M., Bechamps M., Selnes O.A., Baumgartner W.A., et al. Encephalopathy and stroke after coronary artery bypass grafting: incidence, consequences, and prediction. Arch Neurol 59 (2002) 1422-1428
5. McKhann G.M., Grega M.A., Borowicz Jr. L.M., Bailey M.M., Barry S.J., Zeger S.L., et al. Is there cognitive decline 1 year after CABG?. comparison with surgical and nonsurgical controls. Neurology 65 (2005) 991-999
6. Tatemichi T.K., Desmond D.W., Mayeux R., Paik M., Stern Y., Sano M., et al. Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology 42 (1992) 1185-1193
7. Pohjasvaara T., Erkinjuntti T., Vataja R., and Kaste M. Dementia three months after stroke: baseline frequency effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. Stroke 28 (1997) 785-792
8. Vermeer S.E., Koudstaal P.J., Oudkerk M., Hofman A., and Breteler M.M. Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 33 (2002) 21-25
9. Vermeer S.E., Prins N.D., den Heijer T., Hofman A., Koudstaal P.J., and Breteler M.M. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 348 (2003) 1215-1222
10. Goto T., Baba T., Honma K., Shibata Y., Arai Y., Uozumi H., et al. Magnetic resonance imaging findings and postoperative neurologic dysfunction in elderly patients undergoing coronary artery bypass grafting. Ann Thorac Surg 72 (2001) 137-142
11. Snowdon D.A., Greiner L.H., Mortimer J.A., Riley K.P., Greiner P.A., and Markesbery W.R. Brain infarction and the clinical expression of Alzheimer disease. JAMA 277 (1997) 813-817
12. Esiri M.M., Nagy Z., Smith M.Z., Barnetson L., and Smith A.D. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 354 (1999) 919-920
13. Selnes O.A., and Vinters H.V. Vascular cognitive impairment. Nature Clin Pract Neurol 2 (2006) 538-547
14. Kovari E., Gold G., Herrmann F.R., Canuto A., Hof P.R., Michel J.P., et al. Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke 35 (2004) 410-414
15. Hendrie H.C., Albert M.S., Butters M.A., Gao S., Knopman D.S., Launer L.J., et al. The NIH Cognitive and Emotional Health Project: Report of the Critical Evaluation Study Committee. Alzheimer's & Dementia 2 (2006) 12-32
16. Qiu C., von Strauss E., Winblad B., and Fratiglioni L. Decline in blood pressure over time and risk of dementia: a longitudinal study from the Kungsholmen project. Stroke 35 (2004) 1810-1815
17. Peila R., White L.R., Petrovich H., Masaki K., Ross G.W., Havlik R.J., et al. Joint effect of the APOE gene and midlife systolic blood pressure on late-life cognitive impairment: the Honolulu-Asia aging study. Stroke 32 (2001) 2882-2889
18. Forette F., Seux M.L., Staessen J.A., Thijs L., Babarskiene M.R., Babeanu S., et al. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med 162 (2002) 2046-2052
19. Tzourio C., Anderson C., Chapman N., Woodward M., Neal B., MacMahon S., et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 163 (2003) 1069-1075
20. Lithell H., Hansson L., Skoog I., Elmfeldt D., Hofman A., and Olofsson B. The Study on Cognition and Prognosis in the Elderly (SCOPE):outcomes in patients not receiving add-on therapy after randomization. Hypertension 22 (2004) 1605-1612
21. Skoog I., Lithell H., Hansson L., Elmfeldt D., Hofman A., Olofsson B., et al. Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on Cognition and Prognosis in the Elderly (SCOPE). Am J Hypertens 18 (2005) 105-129
22. Li G. Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study. Neurology 9 (2004) 1624-1628
23. Rockwood K. Epidemiological and clinical trials evidence about a preventive role for statins in Alzheimer's disease. Acta Neurol Scand Suppl 185 (2006) 71-77
24. Malouf R., and Birks J. Donepezil for vascular cognitive impairment. Cochrane Database Syst Rev (2004) CD004395
25. Craig D., and Birks J. Galantamine for vascular cognitive impairment. Cochrane Database Syst Rev 25 (2006) CD004746
26. McShane R., Areosa Sastra A., and Minakaran N. Memantine for dementia. Cochrane Database Syst Rev (2006) CD003154
27. Williams P.S., Rands G., Orrel M., and Spector A. Aspirin for vascular dementia. Cochrane Database Syst Rev (2000) CD001296